Latest medullary thyroid cancer Stories
Researchers at the National Institutes of Health (NIH), Bethesda, MD, have taken the first steps to determine if a protein, called Programmed Death Ligand 1 (PD-L1), can help to predict which thyroid cancer patients will most likely have a recurrence of the disease.
Tokyo, Aug 20, 2012 - (JCN Newswire) - Eisai Co., Ltd.
Elderly patients who undergo thyroid surgery are at a much higher risk than their younger counterparts for serious cardiac, pulmonary and infectious complications.
Papillary thyroid cancer accounts for the majority of all thyroid malignancies, which primarily impact women.
A mutant gene long thought to accelerate tumor growth in thyroid cancer patients actually inhibits the spread of malignant cells, showing promise for novel cancer therapies, a Mayo Clinic study has found.
Vandetanib is first drug approved for medullary thyroid cancer SILVER SPRING, Md., April 6, 2011 /PRNewswire-USNewswire/ -- The U.S.
Positron emission tomography (PET) can image metabolic changes following treatment with the protein kinase inhibitor vandetanib, helping to define the therapy response or the effectiveness of the therapeutic agent.
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.